AMN Healthcare AMN Payments For Share Repurchase Program, Excise Tax

Payments For Share Repurchase Program, Excise Tax at other companies

DoximityDOCS

$0-100%

Westamerica BankWABC

$0-100%

ProPetro Holding Corp.PUMP

$132.75K+19.6%

YelpYELP

$304.5K+332%

Vishay Precision GroupVPG

$15K+46.3%

LegalZoom.com, Inc.LZ

$316K+648%

Other financials

Income statement

See full

Revenue$1.4B+99.9%

Gross profit$368.8M+86.2%

Operating income$117.2M+837%

Net income$62.2M+5,793%

EPS (diluted)$1.59+5,400%

Balance sheet

See full

Cash & equivalents$595.0M+528%

Total debt$776.9M-12.4%

Total equity$712.8M-0.3%

Total assets$2.6B+8.7%

Cash flow

See full

Operating cash flow$562.5M+507%

CapEx$7.2M-27.4%

Free cash flow$555.2M+571%

Valuation

See full

Market cap$1.23B-24.1%

Enterprise value$1.41B-48.4%

P/S0.4×-0.2×

Profitability

See full

Gross margin27.6%-2.5pp

Operating margin-9.8%-14.2pp

Net margin-0.9%-0.4pp

FCF margin20.7%+11.6pp

Returns & leverage

See full

Return on equity-4.5%-2.0pp

Debt / equity1.1×-0.2×

Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept amn:PaymentsForShareRepurchaseProgramExciseTax.

The official record: AMN Healthcare’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's payments for share repurchase program, excise tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AMN Healthcare's payments for share repurchase program, excise tax?: AMN Healthcare (AMN) reported payments for share repurchase program, excise tax of $0 in Q4 2025.
How has AMN Healthcare's payments for share repurchase program, excise tax changed year-over-year?: AMN Healthcare's payments for share repurchase program, excise tax decreased by 100.0% year-over-year, from $925.25K to $0.
What does payments for share repurchase program, excise tax mean?: Includes the cash outflows specifically allocated to pay excise taxes triggered by share repurchase activities. This reflects the regulatory cost burden associated with returning capital to shareholders.